TY - JOUR
T1 - Reference equations for evaluation of spirometry function tests in South Asia, and among South Asians living in other countries
AU - Leong, Wei Yee
AU - Gupta, Ananya
AU - Hasan, Mehedi
AU - Mahmood, Sara
AU - Siddiqui, Samreen
AU - Ahmed, Sajjad
AU - Goon, Ian Y.
AU - Loh, Marie
AU - Mina, Theresia H.
AU - Lam, Benjamin
AU - Yew, Yik Weng
AU - Ngeow, Joanne
AU - Lee, Jimmy
AU - Lee, Eng Sing
AU - Riboli, Elio
AU - Elliott, Paul
AU - Tan, Geak Poh
AU - Chotirmall, Sanjay H.
AU - Wickremasinghe, Ananda R.
AU - Kooner, Jaspal S.
AU - Khawaja, Khadija I.
AU - Katulanda, Prasad
AU - Mridha, Malay K.
AU - Jha, Sujeet
AU - Mohan, Anjana Ranjit
AU - Pradeepa, Guha
AU - Kasturiratne, Anuradhani
AU - Chambers, John C.
N1 - Publisher Copyright:
Copyright ©The authors 2022.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Background There are few data to support accurate interpretation of spirometry data in South Asia, a major global region with a high reported burden of chronic respiratory disease. Method We measured lung function in 7453 healthy men and women aged ≥18 years, from Bangladesh, North India, South India, Pakistan and Sri Lanka, as part of the South Asia Biobank study. First, we assessed the accuracy of existing equations for predicting normal forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and FEV1/FVC ratio. Then, we used our data to derive (n=5589) and internally validate (n=1864) new prediction equations among South Asians, with further external validation among 339 healthy South Asians living in Singapore. Results The Global Lung Initiative (GLI) and National Health and Nutrition Examination Survey consistently overestimated expiratory volumes (best fit GLI-African American, mean±SD z-score: FEV1 −0.94±1.05, FVC −0.91±1.10; n=7453). Age, height and weight were strong predictors of lung function in our participants (p<0.001), and sex-specific reference equations using these three variables were highly accurate in both internal validation (z-scores: FEV1 0.03±0.99, FVC 0.04±0.97, FEV1/FVC −0.03±0.99) and external validation (z-scores: FEV1 0.31±0.99, FVC 0.24±0.97, FEV1/FVC 0.16±0.91). Further adjustment for study regions improves the model fit, with highest accuracy for estimation of region-specific lung function in South Asia. Conclusion We present improved equations for predicting lung function in South Asians. These offer the opportunity to enhance diagnosis and management of acute and chronic lung diseases in this major global population.
AB - Background There are few data to support accurate interpretation of spirometry data in South Asia, a major global region with a high reported burden of chronic respiratory disease. Method We measured lung function in 7453 healthy men and women aged ≥18 years, from Bangladesh, North India, South India, Pakistan and Sri Lanka, as part of the South Asia Biobank study. First, we assessed the accuracy of existing equations for predicting normal forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and FEV1/FVC ratio. Then, we used our data to derive (n=5589) and internally validate (n=1864) new prediction equations among South Asians, with further external validation among 339 healthy South Asians living in Singapore. Results The Global Lung Initiative (GLI) and National Health and Nutrition Examination Survey consistently overestimated expiratory volumes (best fit GLI-African American, mean±SD z-score: FEV1 −0.94±1.05, FVC −0.91±1.10; n=7453). Age, height and weight were strong predictors of lung function in our participants (p<0.001), and sex-specific reference equations using these three variables were highly accurate in both internal validation (z-scores: FEV1 0.03±0.99, FVC 0.04±0.97, FEV1/FVC −0.03±0.99) and external validation (z-scores: FEV1 0.31±0.99, FVC 0.24±0.97, FEV1/FVC 0.16±0.91). Further adjustment for study regions improves the model fit, with highest accuracy for estimation of region-specific lung function in South Asia. Conclusion We present improved equations for predicting lung function in South Asians. These offer the opportunity to enhance diagnosis and management of acute and chronic lung diseases in this major global population.
UR - http://www.scopus.com/inward/record.url?scp=85143196992&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85143196992&partnerID=8YFLogxK
U2 - 10.1183/13993003.02962-2021
DO - 10.1183/13993003.02962-2021
M3 - Article
C2 - 35896203
AN - SCOPUS:85143196992
SN - 0903-1936
VL - 60
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 6
M1 - 2102962
ER -